Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maikel V. W. van der Velden"'
Autor:
Mary Kate Hart, Wael El-Amin, Sandor Fritsch, Maikel V. W. van der Velden, Barbara Grohmann-Izay, Gerald Aichinger, P. Noel Barrett, Otfried Kistner, Manuela Koska, Daniel Portsmouth
Publikováno v:
Clinical and Vaccine Immunology. 22:46-55
Studies on candidate pandemic vaccines against avian influenza viruses have focused on H5N1, but viruses of other subtypes, such as A/H9N2, are also considered to have pandemic potential. We investigated the safety and immunogenicity of two immunizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fcf223866848b2bfb4f20cb8beeb57
https://doi.org/10.1128/cvi.00275-14
https://doi.org/10.1128/cvi.00275-14
Autor:
Richard Fritz, Wolfgang Herr, Thomas Dvorak, P. Noel Barrett, Christoph Stephan, Markus Zeitlinger, Eva Distler, Robert Sauermann, Hartmut J. Ehrlich, Gerald Aichinger, Brian A. Crowe, Alexander Geisberger, Daniel Portsmouth, Eva Wagner, Maikel V. W. van der Velden
Publikováno v:
Clinical and Vaccine Immunology. 21:867-876
The development of vaccines against H5N1 influenza A viruses is a cornerstone of pandemic preparedness. Clinical trials of H5N1 vaccines have been undertaken in healthy subjects, but studies in risk groups have been lacking. In this study, the immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea98f9bcd536664191f7afd66a4fa14d
https://doi.org/10.1128/cvi.00065-14
https://doi.org/10.1128/cvi.00065-14
Autor:
Timo Vesikari, Otfried Kistner, Peter Richmond, Thomas Dvorak, Javier Díez-Domingo, Thomas R. Kreil, P. Noel Barrett, Eva Maria Pöllabauer, Bee Wah Lee, Hartmut J. Ehrlich, Sandor Fritsch, Richard Fritz, Maikel V. W. van der Velden, M. Keith Howard, Gerald Aichinger, Daniel Portsmouth
Publikováno v:
Journal of Infectious Diseases. 209:12-23
BACKGROUND: Children are highly vulnerable to infection with novel influenza viruses. It is essential to develop candidate pandemic influenza vaccines that are safe and effective in the pediatric population. METHODS: Infants and children aged 6-35 mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b39699a373570e48cd7858bc93ece507
https://doi.org/10.1093/infdis/jit498
https://doi.org/10.1093/infdis/jit498
Autor:
Alexandra Löw-Baselli, Karima Benamara, Gerald Aichinger, Sandor Fritsch, Herwig Kollaritsch, Maikel V. W. van der Velden, Markus Zeitlinger, Otfried Kistner, Markus Müller, Hartmut J. Ehrlich, Eva Maria Pöllabauer, Timo Vesikari, P. Noel Barrett
Publikováno v:
Vaccine. 30:6127-6135
Background Influenza pandemic preparedness involves priming of the population with pre-pandemic vaccines. Such vaccines should be well tolerated and induce a long-lasting immunological memory that can effectively be boosted with a single dose of pand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9592d1f048c9796213e132663f83f386
https://doi.org/10.1016/j.vaccine.2012.07.077
https://doi.org/10.1016/j.vaccine.2012.07.077
Autor:
Paul A. Tambyah, Hartmut J. Ehrlich, Kwok-Yung Yuen, David S.C. Hui, P. Noel Barrett, Helen M. L. Oh, Alexandra Loew-Baselli, Sandor Fritsch, Annelies Wilder-Smith, Friedrich Maritsch, Gerald Aichinger, Maikel V. W. van der Velden, Otfried Kistner, Borislava G. Pavlova
Publikováno v:
Vaccine. 30:329-335
A successful vaccine development strategy for areas with clustered H5N1 events requires conduct of vaccine trials in potentially non-naive subjects and evaluation of post-vaccination responsiveness. An open-label, randomized, phase I/II study therefo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b718828ba9d580cf0f631a4715366f
https://doi.org/10.1016/j.vaccine.2011.10.088
https://doi.org/10.1016/j.vaccine.2011.10.088
Autor:
Stephen Hall, Peter Richmond, Wolfgang Draxler, Nina Wressnigg, John Aaskov, Maria O'Rourke, Maikel V. W. van der Velden, Andrew Redfern, Gerald Aichinger, Daniel Portsmouth, P. Noel Barrett, William J. H. McBride
Ross River virus (RRV) is endemic in Australia and several South Pacific Islands. More than 90,000 cases of RRV disease, which is characterized by debilitating polyarthritis, were reported in Australia in the last 20 years. There is no vaccine availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1184f36a7f69e2d31fa226bc3e8e20f
https://europepmc.org/articles/PMC4340901/
https://europepmc.org/articles/PMC4340901/
Autor:
Gerald Aichinger, Nicole Hetzelt, Otfried Kistner, Richard Fritz, P. Noel Barrett, Reinhard Ilk, M. Keith Howard, Thomas R. Kreil, Maikel V. W. van der Velden, Daniel Portsmouth, Christine Hohenadl
Publikováno v:
Open Forum Infectious Diseases
Neuraminidase-inhibiting (NAi) antibodies have been reported to be an independent correlate of protection from influenza disease, but the NAi antibody response to influenza vaccination has never been assessed in chronically ill or immunocompromised p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe8fbbd9f8ea32e965f876da703ed23
http://europepmc.org/articles/PMC4281780
http://europepmc.org/articles/PMC4281780
Autor:
Helen M. L. Oh, P. Noel Barrett, Greg Berezuk, Eva Maria Pöllabauer, Hartmut J. Ehrlich, Alexandra Löw-Baselli, Markus Müller, Borislava G. Pavlova, Maikel V. W. van der Velden, Emanuele Montomoli, Friedrich Maritsch, Paul A. Tambyah, Markus Zeitlinger, Otfried Kistner, Sandor Fritsch
Publikováno v:
The Journal of infectious diseases. 200(7)
Novel strategies are required to provide rapid vaccine coverage in the event of an influenza pandemic. A phase I/II dose finding/ formulation study was performed with a whole-virus H5N1 clade 1 A/Vietnam vaccine (2-dose priming regimen) to evaluate s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5831a78be6b6b7209b2cc8277fe347dc
https://pubmed.ncbi.nlm.nih.gov/19712040
https://pubmed.ncbi.nlm.nih.gov/19712040